Delivery Order SPE2DR25D2009-SPE2DR26FJ3S4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $157,951.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, executed on August 27, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $10,529.60 under a firm fixed price contract. This competitively awarded delivery order, with an ultimate completion date of September 30, 2025, represents a continuation of the vendor's ongoing pharmaceutical supply relationship with DLA. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,975.85 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, effective December 4, 2025, with completion targeted for December 26, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The vaccine will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,997.30 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on November 20, 2025, with an ultimate completion date of December 12, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a competitive...
- The Defense Logistics Agency awarded a delivery order valued at $5,098.45 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on November 25, 2025, with an ultimate completion date of December 17, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,032.11 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Varivax vaccine with diluents, valued at $1,019.65 with a completion date of December 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,137.83 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on December 2, 2025, with an ultimate completion date of December 23, 2025, utilizes firm fixed pricing and represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,255.36 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on November 5, 2025, with an ultimate completion date of November 28, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ3S4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $190,672.68 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on December 2, 2025, carries an ultimate completion date of December 23, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively selected to fulfill this vaccine supply requirement. The company maintains an extensive portfolio of federal contracts with DLA covering a wide spectrum of pharmaceutical products and medical supplies for military and veteran healthcare systems. The vaccine delivery supports the Defense Health Agency and broader military healthcare operations, demonstrating AmerisourceBergen's role as a key supplier within the federal medical supply chain. This award exemplifies the company's capability to meet specialized pharmaceutical procurement needs through the DLA's strategic vendor relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $190.7k | 12/1/25 |